Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3020

Actual shortage: 234 (8%)
Anticipated shortage: 20 (1%)
Avoided shortage: 9 (0%)
Resolved: 2757 (91%)

Discontinuation Reports

356

To be discontinued: 22 (6%)
Discontinued: 334 (94%)
Reversed: 0 (0%)

Late reports

142 (4%)

Overdue reports

28 (10%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-OLANZAPINE ODT 15MG TABLET (ORALLY DISINTEGRATING) Resolved 2018-04-02 2018-09-04 44507
APO-OLANZAPINE ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2018-04-02 2018-08-15 44510
APO-OLANZAPINE ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2018-12-12 2019-03-29 69318
APO-OLANZAPINE ODT 15MG TABLET (ORALLY DISINTEGRATING) Resolved 2019-09-04 2019-10-01 92984
APO-OLANZAPINE ODT 15MG TABLET (ORALLY DISINTEGRATING) Resolved 2019-12-05 2020-01-07 100310
APO-OLANZAPINE ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2020-04-13 2020-12-21 111928
APO-OLANZAPINE ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2020-04-13 2020-12-21 111931
APO-OLANZAPINE ODT 15MG TABLET (ORALLY DISINTEGRATING) Resolved 2020-05-08 2020-12-28 114309
APO-OLANZAPINE ODT 20MG TABLET (ORALLY DISINTEGRATING) Resolved 2020-05-08 2020-12-28 114312
APO-OLANZAPINE ODT 20MG TABLET (ORALLY DISINTEGRATING) Resolved 2021-10-29 2021-11-26 148503
APO-OLANZAPINE ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2021-10-29 2021-12-06 148506
APO-OLANZAPINE ODT 20MG TABLET (ORALLY DISINTEGRATING) Resolved 2022-05-20 2022-07-22 161032
APO-OLANZAPINE ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2022-06-17 2022-07-28 162904
APO-OLANZAPINE ODT 15MG TABLET (ORALLY DISINTEGRATING) Resolved 2023-03-02 2023-06-02 185930
APO-OLANZAPINE ODT 20MG TABLET (ORALLY DISINTEGRATING) Resolved 2023-04-06 2023-06-02 188968
APO-OLANZAPINE ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2023-04-27 2023-06-02 190862
APO-OLANZAPINE ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2023-05-19 2023-06-02 192788
APO-OLANZAPINE ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2023-06-29 2023-11-06 196949
APO-OLANZAPINE ODT 20MG TABLET (ORALLY DISINTEGRATING) Resolved 2023-07-21 2023-11-06 199515
APO-OLANZAPINE ODT 20MG TABLET (ORALLY DISINTEGRATING) Resolved 2023-12-15 2024-01-05 213553

Showing 1881 to 1900 of 3020

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO DIMENHYDRINATE TAB 50MG 50MG TABLET Discontinued 2018-09-07 2018-09-15 60435
APO DIMENHYDRINATE TAB 50MG 50MG TABLET Discontinued 2019-01-02 2019-01-02 70787
APO-FUROSEMIDE 20MG TABLET Discontinued 2018-09-07 2018-09-15 60506
APO-FUROSEMIDE 40MG TABLET Discontinued 2018-09-07 2018-09-15 60509
APO-FUROSEMIDE 80MG TABLET Discontinued 2017-03-30 2018-02-05 4719
APO GLYBURIDE TAB 2.5MG 2.5MG TABLET Discontinued 2018-09-07 2019-07-04 60515
APO GLYBURIDE TAB 5MG 5MG TABLET Discontinued 2018-09-07 2018-12-14 60518
APO-HYDROCHLOROTHIAZIDE Discontinued 2019-11-26 2019-11-26 99653
APO-HYDROCHLOROTHIAZIDE 50MG TABLET Discontinued 2018-09-07 2019-02-13 60521
APO-IBUPROFEN 300MG TABLET Discontinued 2018-09-07 2018-09-15 60527
APO-IBUPROFEN 300MG TABLET Discontinued 2019-01-02 2019-01-02 70793
APO-IBUPROFEN 400MG TABLET Discontinued 2018-09-07 2018-09-15 60530
APO-IBUPROFEN 400MG TABLET Discontinued 2019-01-02 2019-01-02 70799
APO-METOPROLOL (TYPE L) 50MG TABLET Discontinued 2018-09-07 2019-02-02 60634
APO-METOPROLOL 50MG TABLET Discontinued 2018-09-07 2019-01-09 60631
APO NAPROXEN TAB 125MG 125MG TABLET Discontinued 2018-09-08 2019-08-08 60663
APO-NAPROXEN 250MG TABLET Discontinued 2017-03-30 2018-02-05 4734
APO-OXAZEPAM 10MG TABLET Discontinued 2018-09-08 2019-08-30 60675
APO-OXAZEPAM 15MG TABLET To be discontinued 2018-09-08 2018-09-08 60678
APO-OXAZEPAM 30MG TABLET Discontinued 2018-09-08 2019-06-12 60681

Showing 21 to 40 of 356